Lack of Benefit With Idalopirdine for Alzheimer Disease: Another Therapeutic Failure in a Complex Disease Process
JAMA
.
2018 Jan 9;319(2):123-125.
doi: 10.1001/jama.2017.19700.
Author
David A Bennett
1
Affiliation
1
Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Ilinois.
PMID:
29318261
DOI:
10.1001/jama.2017.19700
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Alzheimer Disease*
Humans
Grants and funding
P30 AG010161/AG/NIA NIH HHS/United States